AIPTO TechBio
Startup
Quick Overview
Description
- Company Type
- Startup
- Working Model
- Hybrid, Onsite
Company Information
AIPTO TechBio is a spin-off of the German Cancer Research Center (DKFZ) based in Basel. The company utilizes patient-derived tumor models combined with generative AI to enhance the prediction of individual therapy responses and support personalized cancer treatments. The focus is initially on developing solutions for brain cancer.
Technologies
Topics We Work On
- Machine Learning
- AI
- HealthTech
